Skin substitutes: A brief review of types and clinical applications

Oman Medical Journal

Volumn 24, Issue 1, 2009, Pages

  Alrubaiy, Laith ^a   Al Rubaiy, Kathem K ^b  

^a YSBYTY GWYNEDD   (United Kingdom)

^b UNIVERSITY OF BASRAH   (Iraq)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR; HYALURONIC ACID;

ACANTHOSIS; AUTOGRAFT; CELL DIFFERENTIATION; DERMOEPIDERMAL JUNCTION; DISEASE TRANSMISSION; EPIDERMOLYSIS; EXTRACELLULAR MATRIX; FIBROBLAST; HISTOLOGY; HUMAN; HYPERKERATOSIS; KERATINOCYTE; NONHUMAN; OSMOREGULATION; REVIEW; RISK FACTOR; SKIN CANCER; SKIN DEFECT; SKIN GRAFT; STRATUM CORNEUM; TUMOR MICROENVIRONMENT; VITREOUS BODY; WOUND HEALING;

EID: 85068466220     PISSN: 1999768X     EISSN: 20705204     Source Type: Journal    
DOI: 10.5001/omj.2009.2     Document Type: Review

References (15)

1. Horch RE, Jeschke MG, Spilker G, Herndon DN, Kopp J. Treatment of Second-Degree Facial Burns with Allografts-Preliminary Results. Burns 2005; 31:597-602.
2. Lee KH. Tissue-engineered human living skin substitutes: development and clinical application. Yonsei Med J 2000; 41:774-779.
3. Wai-Sun Ho. Skin substitutes: an overview. Ann Coll Surg 2002; 6:102-108.
4. Leigh IM, Watt FM. Keratinocyte methods. Cambridge: Cambridge University Press 1994.
5. Leigh IM, Watt FM. “The culture of human epidermal keratinocytes”, Keratinocyte handbook. Cambridge: Cambridge University Press, 1994 pp 43-51.
6. Bello YM, Falabella AF, Eaglstein WH. Tissue-engineered skin. Current status in wound healing. Am J Clin Dermatol 2001; 2:305-313.
7. Supp DM, Boyce ST. Engineered skin substitutes: practices and potentials. Clin Dermatol 2005; 23:403-412.
8. Shakespeare P, Shakespeare V. Survey: use of skin substitute materials in UK burn treatment centres. Burns 2002; 28:295-297.
9. Shakespeare PG. The role of skin substitutes in the treatment of burn injuries. Clin Dermatol 2005; 23:413-418.
10. Melkun ET, Few JW. The use of biosynthetic skin substitute (Biobrane) for axillary reconstruction after surgical excision for hidradenitis suppurativa. Plast Reconstr Surg 2005; 115:1385-1388.
11. Raguse JD, Gath HJ. The buccal fat pad lined with a metabolic active dermal replacement (Dermagraft) for treatment of defects of the buccal plane. Br J Plast Surg 2004; 57:764-768.
12. Price RD, Myers S, Leigh IM, Navsaria HA. The role of hyaluronic acid in wound healing: assessment of clinical evidence. Am J Clin Dermatol 2005; 6:393-402.
13. Edmonds M, Bates M, Doxford M, Gough A, Foster A. New treatments in ulcer healing and wound infection. Diabetes Metab Res Rev 2000; 16:51-54.
14. Harris PA, di Francesco F, Barisoni D, Leigh IM, Navsaria HA (1999). Use of hyaluronic acid and cultured autologous keratinocytes and fibroblasts in extensive burns. Lancet 1999; 353:35-36.
15. O’Leary R, Arrowsmith M, Wood EJ (2002). Characterization of the living skin equivalent as a model of cutaneous re-epithelialization. Cell Biochem Funct 2002; 20:129-141.